Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort

BACKGROUND: Somatic mutations are important biomarkers for selecting an optimal targeted therapy and predicting outcomes for non-small-cell lung cancer (NSCLC) patients that are often detected from tissue samples. However, tissue samples are not always readily available from these patients. The expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hai-bo, Li, Jie, Yao, Yuan-shan, Yang, Zhen-hua, Zhou, Yin-jie, Chen, Wei, Hu, Tian-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443461/
https://www.ncbi.nlm.nih.gov/pubmed/32884354
http://dx.doi.org/10.2147/CMAR.S254139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443461/
https://www.ncbi.nlm.nih.gov/pubmed/32884354
http://dx.doi.org/10.2147/CMAR.S254139

Ejemplares similares